| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +17.5% |
| Cost of Revenue | $7.0M | +186.7% |
| R&D Expense | $3.9M | +24.4% |
| SG&A Expense | $24.1M | -46.8% |
| Operating Income | -$56.8M | -198.9% |
| Pre-tax Income | -$58.8M | -197.4% |
| Income Tax | $0 | — |
| Net Income | -$58.8M | -197.4% |
| EPS (Basic) | -$177.30 | +50.9% |
| EPS (Diluted) | -$177.30 | +50.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.3M | -66.9% |
| Accounts Receivable | $335K | -38.2% |
| Inventory | $0 | -100.0% |
| Current Assets | $6.3M | -73.0% |
| Total Assets | $10.0M | -81.2% |
| Current Liabilities | $21.5M | +37.2% |
| Long-term Debt | $7.1M | -16.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.8M | +43.6% |
| Capital Expenditures | $20K | -90.1% |
| Investing Cash Flow | -$20K | +89.7% |
| Financing Cash Flow | $17.2M | -50.9% |
| Free Cash Flow | -$27.8M | +43.8% |
| Total Liabilities |
| $34.3M |
| -14.4% |
| Stockholders' Equity | -$24.2M | -283.3% |